Up­dat­ed: Sage's roller coast­er ends in $561M ac­qui­si­tion by Su­per­nus

Sage Ther­a­peu­tics has fi­nal­ly found a buy­er.

It will be ac­quired by Su­per­nus Phar­ma­ceu­ti­cals for ap­prox­i­mate­ly $561 mil­lion, the com­pa­nies an­nounced Mon­day morn­ing.

Su­per­nus is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER